Geriatric Assessment for Older Patients with Non-small Cell Lung Cancer: Daily Practice of Centers Participating in the NVALT25-ELDAPT Trial

ConclusionThe use of GA in clinical practice for patients with lung cancer varied widely across centers regarding instruments and domains. Physicians are uniform in their opinion about indications for GA and the added value for treatment decision-making. Research should focus on manageable instruments and important domains to assess for this heterogeneous group of older patients with lung cancer to optimize treatment selection.Trial registration The NVALT25-ELDAPT trial is registered under trial number NCT02284308. Details are available athttp://www.eldapt.org (predominantly in Dutch).
Source: Lung - Category: Respiratory Medicine Source Type: research